Multivitamins finish 2012 on a high
Described as “the cheapest health insurance a person will ever buy” by Prof Balz Frei from the Linus Pauling Institute at Oregon State University, two high profile studies were published in the Journal of the American Medical Association helped boost the profile of multivitamins.
The first paper reported that a daily multivitamin may reduce the risk of cancer by a modest 8%.
Commenting independently on the study, Prof Frei said: “Given that more than 1.6 million new cancer cases are diagnosed in the U.S. each year, this translates into about 130,000 cancers prevented every year, and with it all the health care costs and human suffering.
“Of course it’s just a supplement, and it’s not a substitute for a good diet and healthy lifestyle. But this study should finally answer all the doubters out there who still think multivitamin supplements have no value. And it further confirms they are completely safe to take.”
Next up was a paper that reported no apparent reduction in the risk of developing heart disease.
Please click here to read our article, Multivitamins may not benefit heart disease risk, but 'don't forget the aim and other potential benefits of supplements
